We are live on ! Find out more
T. Rowe Price Associates

T. Rowe Price Associates Portfolio holdings

AUM $865B
1-Year Est. Return 30.76%
 

T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.

This Fund
S&P 500
This Quarter Est. Return
-2.6%
1 Year Est. Return
+30.76%
3 Year Est. Return
+117.39%
5 Year Est. Return
+143.85%
10 Year Est. Return
+1,089.89%
AUM
$610B
AUM Growth
-$181B
Cap. Flow
-$168B
Cap. Flow %
-27.5%
Top 10 Hldgs %
30.63%
Holding
3,114
New
154
Increased
1,364
Reduced
1,248
Closed
171

Top Buys

Rank Stock Value
1
XOM icon
ExxonMobil
XOM
+$1.76B
2
LLY icon
Eli Lilly
LLY
+$1.4B
3
BAC icon
Bank of America
BAC
+$1.3B
4
TSLA icon
Tesla
TSLA
+$1.19B
5
WFC icon
Wells Fargo
WFC
+$784M

Top Sells

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$6.47B
2
AMZN icon
Amazon
AMZN
+$3.71B
3
YUM icon
Yum! Brands
YUM
+$2.84B
4
CRM icon
Salesforce
CRM
+$2.77B
5
FTV icon
Fortive
FTV
+$2.41B

Sector Composition

Rank Sector Weight
1 Technology 26.06%
2 Healthcare 18.72%
3 Consumer Discretionary 14.62%
4 Financials 10.36%
5 Communication Services 9.01%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
JNJ icon
26
Johnson & Johnson
JNJ
$629B
$4.15B 0.68%
25,428,626
+805,831
+3% +$136M
AZN icon
27
AstraZeneca
AZN
$246B
$4.14B 0.68%
37,692,508
-5,267,390
-12% -$668M
SYK icon
28
Stryker
SYK
$133B
$4.09B 0.67%
20,129,316
+224,264
+1% +$47.2M
CI icon
29
Cigna
CI
$73.3B
$4.02B 0.66%
14,502,445
-1,215,679
-8% -$342M
TEAM icon
30
Atlassian
TEAM
$39.4B
$4.01B 0.66%
19,036,183
-3,657,544
-16% -$854M
ROST icon
31
Ross Stores
ROST
$79.6B
$3.95B 0.65%
46,809,965
-2,847,803
-6% -$242M
GE icon
32
GE Aerospace
GE
$379B
$3.68B 0.6%
95,440,875
-38,723,164
-29% -$1.7B
SCHW
33
Charles Schwab
SCHW
$189B
$3.66B 0.6%
50,820,314
-12,478,146
-20% -$866M
XOM icon
34
ExxonMobil
XOM
$657B
$3.46B 0.57%
39,666,941
+19,230,872
+94% +$1.76B
ASML icon
35
ASML
ASML
$695B
$3.45B 0.57%
8,277,346
-2,714,532
-25% -$1.36B
TMX
36
DELISTED
Terminix Global Holdings, Inc.
TMX
$3.44B 0.56%
1,076,231
-6,432,674
-86% -$275M
HUM icon
37
Humana
HUM
$46.7B
$3.3B 0.54%
6,792,073
-780,378
-10% -$380M
ABBV icon
38
AbbVie
ABBV
$440B
$3.29B 0.54%
24,521,336
-6,286,462
-20% -$902M
DG icon
39
Dollar General
DG
$26.4B
$3.27B 0.54%
13,548,882
-5,359,050
-28% -$1.32B
CMG icon
40
Chipotle Mexican Grill
CMG
$41.3B
$3.16B 0.52%
104,867,000
-30,473,700
-23% -$945M
BAC icon
41
Bank of America
BAC
$453B
$3.13B 0.51%
103,645,596
+38,870,780
+60% +$1.3B
AMD icon
42
Advanced Micro Devices
AMD
$788B
$3.07B 0.5%
48,415,570
-5,140,046
-10% -$438M
PM icon
43
Philip Morris
PM
$290B
$2.94B 0.48%
35,468,228
+6,558,762
+23% +$626M
ROP icon
44
Roper Technologies
ROP
$39.1B
$2.87B 0.47%
7,946,885
-4,081,655
-34% -$1.66B
WMT icon
45
Walmart Inc
WMT
$923B
$2.79B 0.46%
64,576,239
-7,181,874
-10% -$315M
GS icon
46
Goldman Sachs
GS
$302B
$2.79B 0.46%
9,478,109
+126,277
+1% +$40.9M
TMUS icon
47
T-Mobile US
TMUS
$190B
$2.74B 0.45%
20,381,357
+534,654
+3% +$75.1M
NFLX icon
48
Netflix
NFLX
$309B
$2.69B 0.44%
114,051,420
+19,910,990
+21% +$442M
SRE icon
49
Sempra
SRE
$56.2B
$2.55B 0.42%
34,072,722
-9,076,264
-21% -$734M
CNC icon
50
Centene
CNC
$33.1B
$2.43B 0.4%
31,270,675
+855,690
+3% +$76.5M

Similar funds

T. Rowe Price Associates's Q3 2022 Portfolio in Review

As of Q3 2022, T. Rowe Price Associates held 3,114 positions worth $610B, down 23% from $791B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

T. Rowe Price Associates withdrew a net $168B in Q3 2022, closing 171 positions and reducing 1,248 holdings. Its most notable exit was Alcon, an estimated $1.51B position sold in full.

By sector, the portfolio is most concentrated in Technology at 26% of assets, down from 27% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, T. Rowe Price Associates opened a new position in Corebridge Financial worth $194M.

  • T. Rowe Price Associates's largest Q3 2022 buy was Corebridge Financial: 9,831,688 shares worth $194M.
  • T. Rowe Price Associates added most to ExxonMobil in Q3 2022, an estimated $1.76B increase.
  • T. Rowe Price Associates's biggest Q3 2022 reduction was Microsoft, cutting an estimated $6.47B.
  • T. Rowe Price Associates fully exited Alcon in Q3 2022, selling an estimated $1.51B.
  • T. Rowe Price Associates's ten largest holdings make up 31% of its $610B portfolio in Q3 2022.
  • T. Rowe Price Associates opened 154 new positions and closed 171 in Q3 2022.
  • T. Rowe Price Associates's portfolio value fell 23% quarter-over-quarter to $610B.

Based on T. Rowe Price Associates's 13F filing for Q3 2022, filed 14 Nov 2022.